The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Intravenous and intraperitoneal paclitaxel with S-1 for refractory pancreatic cancer with malignant ascites: An interim analysis.
Naminatsu Takahara
No relevant relationships to disclose
Hiroyuki Isayama
No relevant relationships to disclose
Yousuke Nakai
No relevant relationships to disclose
Takashi Sasaki
No relevant relationships to disclose
Hironori Ishigami
No relevant relationships to disclose
Hironori Yamaguchi
No relevant relationships to disclose
Hirofumi Kogure
No relevant relationships to disclose
Natsuyo Yamamoto
No relevant relationships to disclose
Naoki Sasahira
No relevant relationships to disclose
Kenji Hirano
No relevant relationships to disclose
Minoru Tada
No relevant relationships to disclose
Joji Kitayama
No relevant relationships to disclose
Toshiaki Watanabe
No relevant relationships to disclose
Kazuhiko Koike
No relevant relationships to disclose